General articles

Sequencing projects come in many different forms. At Gencove, we’ve seen and supported a broad range of species and sample types. Occasionally, we receive projects that our partner service labs can't support using standard procedures, necessitating bespoke and innovative solutions.

Effectively we are rapidly approaching a world where sequencing costs per se are irrelevant to companies looking to implement genetic testing at massive scale. The scientific implications of this are fun to consider, but it’s also worth thinking about the overall business implications.

As we close the book on 2023, the Gencove team was busier than ever in the pursuit our mission: a healthier and more sustainable civilization through the application of ubiquitous sequencing. Our work with our partners spanned species and populations, today we look back on a few key highlights.

At Gencove, we have repeatedly seen the complexity and insufficiency of existing tools limit research teams from fully unlocking the value of their genetic data. Gencove Explorer analysis cloud represents a full-stack solution that addresses the challenges that exist with currently data solutions, in a single integrated platform and with a minimal learning curve. In doing so, Explorer accelerates the rate at which scientists can answer critical biological questions, and furthers our goal of delivering insights that advance global health and sustainability.

Low-pass whole genome sequencing is an approach that strikes a balance between the cost-efficiency of microarrays and the broad genomics insights provided by high coverage WGS

We are pleased to announce a new feature that allows users to customize project configurations on the Gencove platform and provides our users with greater control over their projects.

Samples already on the Gencove platform can now be easily reprocessed using a different project configuration.

To help move towards Gencove’s vision of ubiquitous sequencing, we’re happy to announce support for our deep whole genome sequencing (WGS) pipeline!

To offer another option for scientists and companies seeking whole genome sequencing and analysis, Gencove evaluated the ability to process low-pass sequencing data derived from the AVITI™ System in two studies.

Whether it is genotyping a whole herd or building support for new species and breeds, at Gencove, we’re continually looking for ways to empower companies and scientists to discover more using sequencing. That’s why we’re excited to share the latest milestone in this pursuit with the launch of InfiniSEEK™– available now through NEOGEN.

The vision of Gencove is that the universal application of genomics will result in a healthier and more sustainable civilization.